Why Tilray Is Hitting All-Time Highs

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why Tilray Is Hitting All-Time Highs

© Thinkstock

Tilray Inc. (NASDAQ: TLRY) shares hit an all-time high on Monday after the company announced a new partnership with the Nova Scotia Liquor Corp. (NSLC) to receive an initial purchase order for adult-use cannabis.

The purchase order would allow Tilray, one of 14 cannabis producers selected by NSLC, to supply the province of Nova Scotia with a diverse array of cannabis products in anticipation of the launch of the adult-use market on October 17, 2018.

Tilray intends to fulfill NSLC purchase orders through its affiliate High Park Holdings, which was formed to produce and distribute a broad-based portfolio of adult-use cannabis brands and products.

[nativounit]

NSLC’s initial purchase order from Tilray includes these seleced brands:

  • Marley Natural, crafted with deep respect for wellness and the positive potential of the herb, Marley Natural offers four categories of cannabis whole-flower and pre-rolls; Marley Green (hybrid), Marley Gold (sativa), Marley Red (high-CBD) and Marley Black (indica).
  • CANACA, offers the best of Canadian bud in a variety of celebrated cannabis strains available in whole-flower and pre-rolls.

Adine Fabiani-Carter, chief marketing officer at High Park, commented:

We’re thrilled High Park will have the opportunity to supply the province of Nova Scotia with a safe, secure and reliable source of adult-use cannabis products. Our intention is to deliver on the high expectations Nova Scotians have of us by cultivating and distributing a portfolio of world-class adult-use brands and products that will lead the market in quality, excellence and craftsmanship.

Shares of Tilray were last seen up 21% at $52.95, with a consensus analyst price target of $34.67 and a 52-week range of $20.10 to $54.16.

[recirclink id=488317]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618